Breast implants remain one of the most studied and researched medical devices. It is important that patients understand the risk and concerns surrounding the FDA silicone cohesive gel breast implants. According to a recent industry article patients should understand there is a slight risk that could be associated with silicone cohesive gel breast implants .The FDA requires full disclosure to patients. The Food and Drug Administration recently informed consumers to an Association between Anaplastic Large Call Lymphoma, a form of cancer known as ALCL and breast implants. The occurrence of this condition is extremely rare; it is said that factually a woman has a better chance of being struck by lightning than developing ALCL.